Trial Information

Summary: A study to treat the symptoms of overactive bladder.

This is a 12-week placebo controlled study to evaluate the efficacy and safety of daily dosing with Oxybutynin Topical Gel to treat the symptoms of overactive bladder.

Patient Eligibility Criteria:

• Male or non-pregnant female of 18 years or older
• Frequency of 8 or more voids in a 24 hour period with 4 or more urge incontinence episodes measured by a 3 day diary
• History of overactive bladder with symptoms of urgency, urge urinary incontinence, and urinary frequency, with or without neurological disease
• History of pure urge or mixed urinary incontinence with a predominance of urge incontinence episodes (multiple wetting accidents due to sudden and frequent urges to go to the bathroom)
• No urinary tract infection, prostatitis, hematuria (blood in the urine), bladder tumor, bladder stone, prostate cancer, that may cause urinary incontinence or urgency
• No interstitial cystitis
• No male PSA greater than 4 ng/ml. Patients with PSA =10 ng/mL and negative prostate biopsies within 1 year prior to study are acceptable
• No prostate biopsy positive for prostate cancer

Qualified participants will receive:

• Study-related medication
• Study-related medical tests
• Study-related laboratory services

Additionally participants will be compensated for their time and travel. Please note that there are additional eligibility criteria. The study center will determine if you meet all of the criteria.

Study personnel will explain the trial in detail and answer any questions you may have if you do qualify for the study. You can then decide whether or not you wish to participate. If you do not qualify for the trial, study personnel will explain the reasons

If you would like to learn more about participating in this study, please send an e-mail message using the form below.